Your browser doesn't support javascript.
loading
In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia.
de Araújo, Jéssica Nayara Góes; de Oliveira, Victor Fernandes; Borges, Jéssica Bassani; Dagli-Hernandez, Carolina; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de; Bastos, Gisele Medeiros; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Hirata, Rosario Dominguez Crespo; Hirata, Mario Hiroyuki; Luchessi, André Ducati; Silbiger, Vivian Nogueira.
Afiliação
  • de Araújo JNG; Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal 59078-900, Brazil.
  • de Oliveira VF; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Borges JB; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil; Laboratory of Molecular Research in Cardiology, Institute Dante Pazzanese of Cardiology, Sao Paulo 04012-909, Brazil.
  • Dagli-Hernandez C; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Marçal EDSR; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Freitas RCC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Bastos GM; Laboratory of Molecular Research in Cardiology, Institute Dante Pazzanese of Cardiology, Sao Paulo 04012-909, Brazil; Medical Clinic Division, Institute Dante Pazzanese of Cardiology, Sao Paulo 04012-909, Brazil.
  • Gonçalves RM; Medical Clinic Division, Institute Dante Pazzanese of Cardiology, Sao Paulo 04012-909, Brazil.
  • Faludi AA; Medical Clinic Division, Institute Dante Pazzanese of Cardiology, Sao Paulo 04012-909, Brazil.
  • Jannes CE; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao, Paulo 05403-900, Brazil.
  • Pereira ADC; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao, Paulo 05403-900, Brazil.
  • Hirata RDC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Hirata MH; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Luchessi AD; Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal 59078-900, Brazil; Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.
  • Silbiger VN; Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal 59078-900, Brazil; Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil. Electronic address: vivian.silbige
Gene ; 849: 146908, 2023 Jan 15.
Article em En | MEDLINE | ID: mdl-36167182

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / Hiperlipoproteinemia Tipo II Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Gene Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertase 9 / Hiperlipoproteinemia Tipo II Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Gene Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda